12-7368959-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174941.6(CD163L1):c.4046C>T(p.Ser1349Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_174941.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151442Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250814Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135600
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461466Hom.: 0 Cov.: 29 AF XY: 0.00000550 AC XY: 4AN XY: 727022
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151560Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74094
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4046C>T (p.S1349L) alteration is located in exon 16 (coding exon 16) of the CD163L1 gene. This alteration results from a C to T substitution at nucleotide position 4046, causing the serine (S) at amino acid position 1349 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at